JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 10 940-946
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winchell, H. S.
Right arrow Articles by Lin, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winchell, H. S.
Right arrow Articles by Lin, T. H.

Development of I-123-Labeled Amines for Brain Studies: Localization of I-123 Iodophenylalkyl Amines in Rat Brain

H. S. Winchell, R. M. Baldwin and T. H. Lin

Medi-Physics, Inc., Emeryville, California

Correspondence: For reprints contact: H. S. Winchell, MD, 1 Via Oneg, Lafayette, CA 94549.

ABSTRACT

Localization in rat brain of forty iodophenylalkyl amines labeled with I-123 was evaluated in an attempt to develop I-123-labeled amines useful for brain studies. For the amines studied, the highest activity in brain and the brain-to-blood activity ratios ranked p > m > o as related to iodine position on the benzene ring: for alkyl groups the rank order was {alpha}-methylethyl > ethyl > methyl > none; for N additions it was single lipophilic group > H > two lipophilic groups. It is suggested that introduction of a halogen into the ring structure of many amines results in greater concentration of the agent in brain than is seen with the nonhalogenated parent compound.

Thirty-four of the forty compounds showed higher rat brain activity, and higher brain-to-blood activity ratios at 5 min than did [123I]-4-iodoantipyrine. Ten of the compounds showed a tenfold or greater brain-to-blood ratio at 5 min than did [123I]-4-iodoantipyrine. We propose that while initial uptake of these agents in the brain is a consequence of their lipophilicity and that such initial uptake may be a measure of perfusion, progressive brain accumulation of these agents is probably a combined consequence of intravascular/extravascular intracerebral pH gradients, favorable brain lipid/aqueous partition coefficients, and the affinity of the agents for high-capacity, relatively nonspecific binding sites for amines located in the brain and/or brain capillary endothelium.

The agent N-isopropyl-p-iodoamphetamine was chosen for further study because, in the rat, it showed high brain activity (1.57%/g) and brain-blood ratio (12.6) at 5 min; these increased to 2.14%/g and 20.7 at 60 min (R isomer) following its intravenous administration.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
Y. Ayada, Y. Tsuda, T. Takahashi, M. Kitadai, M. Ohkawa, H. Matsuo, and Y. Tsuda
Volume of Infarction and Blood Flow in Cerebral Embolism
Angiology, March 1, 1997; 48(3): 223 - 228.
[Abstract] [PDF]


Home page
Vasc MedHome page
D. C. Costa
Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
Vascular Medicine, September 1, 1990; 1(2): 179 - 201.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.